VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 634 filers reported holding VANECK VECTORS ETF TR in Q3 2022. The put-call ratio across all filers is 0.65 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $825,000 | -15.4% | 34,185 | -4.0% | 0.04% | -14.6% |
| Q2 2022 | $975,000 | -49.8% | 35,624 | -29.4% | 0.04% | -45.3% |
| Q1 2022 | $1,944,000 | +53.2% | 50,487 | +26.3% | 0.08% | +27.1% |
| Q4 2021 | $1,269,000 | +3.3% | 39,980 | -3.5% | 0.06% | -1.7% |
| Q3 2021 | $1,228,000 | -54.3% | 41,410 | -47.6% | 0.06% | -50.8% |
| Q2 2021 | $2,688,000 | +58.1% | 79,102 | +51.2% | 0.12% | +37.1% |
| Q1 2021 | $1,700,000 | -2.2% | 52,312 | +8.4% | 0.09% | -4.3% |
| Q4 2020 | $1,738,000 | +110.7% | 48,238 | +129.0% | 0.09% | +36.8% |
| Q3 2020 | $825,000 | +160.3% | 21,067 | +48.1% | 0.07% | +21.4% |
| Q2 2018 | $317,000 | +42.8% | 14,225 | +40.8% | 0.06% | +300.0% |
| Q1 2018 | $222,000 | -12.6% | 10,104 | -7.7% | 0.01% | -48.1% |
| Q4 2017 | $254,000 | -12.7% | 10,949 | -0.7% | 0.03% | -34.1% |
| Q3 2016 | $291,000 | – | 11,025 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |